JA

Jatin Ameta

Active Director Director DIN 09205574
DIN 09205574 First appointment Jun 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Jatin Ameta

Data last updated:

Jatin Ameta is a Director at Udaipur Med Private Limited (since 2021). The company operates in Non-Profit Organizations. Udaipur Med Private Limited reported revenue of ₹27,454 (FY 2024).

DIN 09205574
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 16 Jun 2021
Oldest Company Age 5 yrs
Largest company Udaipur Med Private Limited · ₹27,454 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Udaipur Med Private Limited U85300RJ2021PTC075376
Director16 Jun 20212021₹27,454 (FY 2024)Active

Board colleagues of Jatin Ameta

NameDINCompanyDesignation
Damanish Vaishnav09205575Udaipur Med Private LimitedDirector

Directorship timeline

Open interactive timeline →
Udaipur Med Private Limited
Premium access

Shareholding and investment profile for Jatin Ameta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jatin Ameta

Jatin Ameta currently holds 1 directorship: Udaipur Med Private Limited (Director, since 16 Jun 2021, revenue ₹27,454 (FY 2024)).

Jatin Ameta was first appointed on 16 Jun 2021 as Director at Udaipur Med Private Limited.

The current boards of Jatin Ameta's companies include Damanish Vaishnav (Udaipur Med Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available